SYNTHETIC DEMONSTRATION — no real student or patient. Not a medical device.

fertility

Recurrent Miscarriage: How Many Before Testing and What Comes Next

Most major reproductive medicine organizations now recommend a formal evaluation after two consecutive pregnancy losses — not three. Testing looks for genetic, anatomic, hormonal, immune, and clotting factors. Two losses in a row, or one loss with additional risk factors, warrants a specialist referral.

Talk to a clinician

Gale can match you with a licensed clinician for a visit.

Find care →

Has the guideline changed — is it two or three miscarriages?

For many years, the standard threshold was three consecutive pregnancy losses before initiating a formal evaluation. That threshold has shifted. The American Society for Reproductive Medicine (ASRM) defines recurrent pregnancy loss (RPL) as two or more failed pregnancies and recommends evaluation at that point. 1 The American College of Obstetricians and Gynecologists notes that evaluation after two losses is reasonable and supported by the evidence. 2

In practice, a thoughtful clinician may begin parts of the evaluation after a second loss, especially if: - You are over 35 (age reduces the margin of time) - Either loss occurred after the first trimester - You have a known medical condition (thyroid disorder, clotting disorder, diabetes) that could be contributing - The losses have been emotionally devastating and you want answers sooner

You do not need to wait for a third loss before asking to be evaluated.

What causes recurrent pregnancy loss?

The majority of individual miscarriages are caused by chromosomal abnormalities in the embryo — random copying errors during cell division that are not heritable and not related to either parent's health. With recurrent loss, clinicians look for underlying factors that could increase the frequency of loss. [1, 2]

Genetic factors - Chromosomal abnormalities in the embryo (most common reason for any individual loss) - Chromosomal rearrangements in one or both parents (translocation) — uncommon but identifiable with a blood test called a karyotype

Uterine structural factors - Uterine septum (a fibrous partition inside the uterus — the most common correctable structural cause) - Submucosal fibroids or polyps that distort the uterine cavity - Asherman syndrome (scar tissue from prior procedures)

Hormonal factors - Uncontrolled thyroid disease (both hypothyroid and hyperthyroid states increase miscarriage risk) - Poorly controlled diabetes - Luteal phase deficiency (low progesterone support in the second half of the cycle) - PCOS — the relationship is complex and debated, but hormonal dysregulation may play a role 3

Thrombophilic (clotting) disorders - Antiphospholipid syndrome (APS) — a treatable immune condition that increases clotting and is one of the most actionable causes of RPL - Inherited thrombophilias (such as Factor V Leiden) — the strength of evidence for treatment varies

Unexplained In a substantial proportion of couples, no cause is found after thorough evaluation. This is genuinely common and does not mean the evaluation was wasted — it rules out treatable causes and provides some reassurance about future outlook.

What does the evaluation include?

A standard RPL workup typically includes: 1

  • Parental karyotype (chromosomes): A blood draw from each partner to check for inherited chromosomal rearrangements
  • Uterine cavity evaluation: Sonohysterogram (saline-infusion ultrasound) or hysteroscopy to look at the inside of the uterus
  • Antiphospholipid antibody testing: Lupus anticoagulant, anticardiolipin antibodies, and anti-beta-2-glycoprotein I antibodies — tested twice at least 12 weeks apart to confirm a positive result
  • Thyroid-stimulating hormone (TSH): Thyroid disorders are common and treatable
  • Fasting glucose or hemoglobin A1c: If diabetes is suspected
  • Progesterone: Sometimes checked, though the role of progesterone supplementation in unexplained RPL is an active area of research

Some clinicians offer additional panels (thrombophilia screening beyond APS, natural killer cell testing, immune panels); the evidence for these varies, and ASRM guidance is more conservative about their clinical utility. 1

What is the outlook after recurrent loss?

The prognosis for eventual live birth is better than many people expect, even after multiple losses. For couples with no identifiable cause, the live birth rate in subsequent pregnancies is estimated to be around 60–70% without any treatment — reflecting the fact that many losses are from random chromosomal events rather than a fixed recurring cause.

When a cause is identified and treated — for example, antiphospholipid syndrome managed with low-dose aspirin and heparin, or a uterine septum repaired — outcomes generally improve. 1

Time and age matter, particularly after 35. If no cause is found and treatment options are limited, preimplantation genetic testing (PGT) with IVF is one option that can reduce the rate of chromosomally abnormal embryo transfers — though it does not eliminate recurrence risk entirely.

Common questions

Do I need to wait for three miscarriages before a doctor will test me?

No. Current ASRM guidance supports evaluation after two consecutive pregnancy losses, and many clinicians will begin the workup after two losses. If you have had two losses, ask your OB-GYN or seek a referral to a reproductive endocrinologist.

Should we test the tissue from the miscarriage?

Testing the products of conception (POC) for chromosomal abnormalities can provide useful information — a chromosomally abnormal result suggests a random event rather than a recurring cause, while a normal chromosomal result in the embryo shifts attention toward the maternal evaluation. Ask your clinician whether POC testing is an option.

What is the most important treatable cause to look for?

Antiphospholipid syndrome (APS) is one of the most clinically significant because it is both identifiable by blood test and treatable with low-dose aspirin and blood-thinning medication. Testing for it is a standard part of the RPL evaluation.

Is a male-factor evaluation part of RPL testing?

Sperm DNA fragmentation testing is sometimes discussed in the context of RPL, though the evidence linking it to recurrent loss and the benefit of treating high fragmentation is still evolving. ASRM guidance does not yet include it as a routine standard test, but some specialists offer it.

How long do I need to wait before trying again after a loss?

ACOG guidance notes that there is no strong medical reason to wait more than one or two normal cycles before trying again, and that earlier attempts do not increase complication risk for most people. Emotional readiness matters as much as physical timing.

Talk to a clinician

Gale can match you with a licensed clinician for a visit.

Find care →

Signs that warrant prompt evaluation — not a wait-and-see approach

  • —Heavy bleeding, severe pain, or fever after a pregnancy loss — seek same-day care
  • —Two or more consecutive losses — request a formal evaluation rather than waiting for a third
  • —Any loss in the second trimester (13 weeks or later), which warrants evaluation after a single event
  • —Known medical conditions (thyroid disease, clotting disorder, diabetes) present alongside losses

If you are currently pregnant and experiencing heavy bleeding, severe pelvic pain, or fever, go to the nearest emergency department or call 911.

This article provides general health education and is not a substitute for personalized medical evaluation. A reproductive endocrinologist or maternal-fetal medicine specialist is the appropriate clinician for recurrent pregnancy loss workup and management.

References

  1. 1.Practice Committee of the American Society for Reproductive Medicine (2012). Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertility and Sterility. doi:10.1016/j.fertnstert.2012.06.048 ✓Definition of RPL as two or more losses, evaluation threshold, standard workup components, and prognosis data
  2. 2.American College of Obstetricians and Gynecologists (2018). ACOG Practice Bulletin No. 200: Early Pregnancy Loss. Obstetrics & Gynecology. doi:10.1097/AOG.0000000000002899 ✓ACOG position supporting evaluation after two consecutive pregnancy losses
  3. 3.American College of Obstetricians and Gynecologists (2018). ACOG Practice Bulletin No. 194: Polycystic Ovary Syndrome. Obstetrics & Gynecology. doi:10.1097/AOG.0000000000002656 ✓PCOS as a hormonal condition associated with reproductive complications including possible increased miscarriage risk

3 sources, numbered by first appearance. General health information, not medical advice — synthetic demonstration content.